CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
-6.85%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(-8.5%)
Cap. Flow
+$903K
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
38.45%
Holding
73
New
4
Increased
25
Reduced
5
Closed
10
Top Buys
| 1 |
CVS Health
CVS
|
$1.77M |
| 2 |
Baidu
BIDU
|
$1.3M |
| 3 |
Cohu
COHU
|
$993K |
| 4 |
First Financial Corporation Common Stock
THFF
|
$959K |
| 5 |
Talos Energy
TALO
|
$911K |
Top Sells
| 1 |
American Superconductor
AMSC
|
$3.38M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
$2.96M |
| 3 |
Incyte
INCY
|
$1.71M |
| 4 |
First Horizon
FHN
|
$1.54M |
| 5 |
Tejon Ranch
TRC
|
$693K |
Sector Composition
| 1 | Healthcare | 35.69% |
| 2 | Technology | 11.09% |
| 3 | Materials | 10.64% |
| 4 | Consumer Staples | 8.17% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
51
Verona Pharma
VRNA
$9.16B
| $506K | 0.46% | 35,000 | – | – |
|
52
Femasys
FEMY
$11.6M
| $485K | 0.44% | 425,000 +25,000 | +6% | +$28.5K |
|
53
Battalion Oil
BATL
$19.4M
| $468K | 0.43% | 140,000 +10,000 | +8% | +$33.4K |
|
54
Assertio
ASRT
$80.4M
| $434K | 0.4% | 350,000 +5,000 | +1% | +$6.2K |
|
55
Eledon Pharmaceuticals
ELDN
$155M
| $422K | 0.39% | 160,000 | – | – |
|
56
Edesa Biotech
EDSA
$16.3M
| $385K | 0.35% | 90,000 +28,000 | +45% | +$120K |
|
57
Lantern Pharma
LTRN
$44.1M
| $374K | 0.34% | 80,000 +15,000 | +23% | +$70.1K |
|
58
Cognition Therapeutics
CGTX
$179M
| $332K | 0.3% | 200,000 +25,000 | +14% | +$41.5K |
|
59
Compass Therapeutics
CMPX
$483M
| $310K | 0.28% | 310,000 | – | – |
|
60
Cadence Bank
CADE
$7.01B
| $283K | 0.26% | 10,000 | – | – |
|
61
Elicio Therapeutics
ELTX
$172M
| $206K | 0.19% | 50,000 -25,000 | -33% | -$103K |
|
|
KRON
62
DELISTED
Kronos Bio
KRON
| $167K | 0.15% | 135,000 -115,000 | -46% | -$143K |
|
63
Gain Therapeutics
GANX
$71.5M
| $115K | 0.11% | 90,000 | – | – |
|
64
Cartesian Therapeutics
RNAC
$261M
| – | – | -305,482 | Closed | -$199K |
|
|
65
American Superconductor
AMSC
$2.25B
| – | – | -250,000 | Closed | -$3.38M |
|
66
BioCardia
BCDA
$11.5M
| – | – | -700,000 | Closed | -$285K |
|
|
67
First Horizon
FHN
$11.5B
| – | – | -100,000 | Closed | -$1.54M |
|
|
68
Incyte
INCY
$16.5B
| – | – | -30,000 | Closed | -$1.71M |
|
|
69
Rigel Pharmaceuticals
RIGL
$697M
| – | – | -2,000,000 | Closed | -$2.96M |
|
70
Smith Micro Software
SMSI
$15.5M
| – | – | -600,000 | Closed | -$207K |
|
|
71
Tejon Ranch
TRC
$468M
| – | – | -45,000 | Closed | -$693K |
|
72
Bristow Group
VTOL
$1.11B
| – | – | -15,377 | Closed | -$418K |
|
|
PVLA
73
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| – | – | -575,000 | Closed | -$105K |
|